Wang et al. found that ATAD2/AAA+ nuclear coregulatory cancer associated (ANCCA) may serve as a promising biomarker for the treatment and prognosis of squamous cell lung carcinoma [40]. The gene discussed is ATAD2; the disease is squamous cell lung carcinoma.